Evidence map›Paper›PMID 32161175›Full record

ArticleJournal of virology2020

Comprehensive Characterization of Transcriptional Activity during Influenza A Virus Infection Reveals Biases in Cap-Snatching of Host RNA Sequences.

Sara Clohisey, Nicholas Parkinson, Bo Wang, Nicolas Bertin, Helen Wise, Andru Tomoiu, FANTOM5 Consortium, Kim M Summers, Ross W Hendry, Piero Carninci and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Respiratory viruses: New frontiers-a Keystone Symposia report.Annals of the New York Academy of Sciences · 2023
    Article
  5. Accessory Gene Products of Influenza A Virus.Cold Spring Harbor perspectives in medicine · 2021
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Sara ClohiseyDivision of Genetics and Genomics, The Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0001-7489-9846
Nicholas ParkinsonDivision of Genetics and Genomics, The Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom.
Bo WangDivision of Genetics and Genomics, The Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom.
Nicolas BertinRIKEN Center for Life Sciences Technologies, Yokohama, Japan.
Helen WiseDivision of Infection and Immunity, The Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom.
Andru TomoiuDivision of Genetics and Genomics, The Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom.
FANTOM5 Consortium
Kim M SummersMater Research Institute-University of Queensland, Brisbane, Australia.
Ross W HendryDivision of Genetics and Genomics, The Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom.
Piero CarninciRIKEN Preventive Medicine and Diagnosis Innovation Program, Wako, Japan.
Alistair R R ForrestHarry Perkins Institute of Medical Research, Nedlands, Australia.
Yoshihide HayashizakiRIKEN Preventive Medicine and Diagnosis Innovation Program, Wako, Japan.
Paul Digard *Division of Infection and Immunity, The Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0002-0872-9440
David A Hume *Mater Research Institute-University of Queensland, Brisbane, Australia david.hume@uq.edu.au j.k.baillie@ed.ac.uk.
J Kenneth Baillie *Division of Genetics and Genomics, The Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom david.hume@uq.edu.au j.k.baillie@ed.ac.uk.ORCID 0000-0001-5258-793X
Roslin Institute · GBRIKEN · JPTranslational Research Institute · AUCE Technologies (United Kingdom) · GBHarry Perkins Institute of Medical Research · AU

Funding

Biotechnology and Biological Sciences Research Council BB/J004324/1Biotechnology and Biological Sciences Research Council BB/P013740/1Wellcome Trust 103258/Z/13/AWellcome Trust 103258/Z/13/Z
6 · The paper itself

Abstract

Macrophages in the lung detect and respond to influenza A virus (IAV), determining the nature of the immune response. Using terminal-depth cap analysis of gene expression (CAGE), we quantified transcriptional activity of both host and pathogen over a 24-h time course of IAV infection in primary human monocyte-derived macrophages (MDMs). This method allowed us to observe heterogenous host sequences incorporated into IAV mRNA, "snatched" 5' RNA caps, and corresponding RNA sequences from host RNAs. In order to determine whether cap-snatching is random or exhibits a bias, we systematically compared host sequences incorporated into viral mRNA ("snatched") against a complete survey of all background host RNA in the same cells, at the same time. Using a computational strategy designed to eliminate sources of bias due to read length, sequencing depth, and multimapping, we were able to quantify overrepresentation of host RNA features among the sequences that were snatched by IAV. We demonstrate biased snatching of numerous host RNAs, particularly small nuclear RNAs (snRNAs), and avoidance of host transcripts encoding host ribosomal proteins, which are required by IAV for replication. We then used a systems approach to describe the transcriptional landscape of the host response to IAV, observing many new features, including a failure of IAV-treated MDMs to induce feedback inhibitors of inflammation, seen in response to other treatments.

Indexed as

Base SequenceBiasGene Regulatory NetworksHost Microbial InteractionsHumansInfluenza A virusInfluenza, HumanLipopolysaccharidesMacrophagesRNA CapsRNA-Dependent RNA PolymeraseRNA, MessengerRNA, Small NuclearRNA, ViralTranscription, GeneticVirus ReplicationLipopolysaccharidesRNA CapsRNA-Dependent RNA PolymeraseRNA, MessengerRNA, Small NuclearRNA, ViralCAGEcap-snatchinginfluenzamacrophagesNGS

Identifiers

PMID32161175
PMCPMC7199409
OpenAlexW3010619515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.